Barroso-Sousa, R. et al. 2019. TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC). Mastology. 29, 3 (Sep. 2019), 5. DOI:https://doi.org/10.29289/259453942019v29s1g04.